These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 19494806)
1. Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Bergen AW; Conti DV; Van Den Berg D; Lee W; Liu J; Li D; Guo N; Mi H; Thomas PD; Lessov-Schlaggar CN; Krasnow R; He Y; Nishita D; Jiang R; McClure JB; Tildesley E; Hops H; Tyndale RF; Benowitz NL; Lerman C; Swan GE Neuropsychopharmacology; 2009 Sep; 34(10):2252-64. PubMed ID: 19494806 [TBL] [Abstract][Full Text] [Related]
2. Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European-Americans. Lou XY; Ma JZ; Sun D; Payne TJ; Li MD Hum Mol Genet; 2007 Jan; 16(2):142-53. PubMed ID: 17164261 [TBL] [Abstract][Full Text] [Related]
3. Genetic variants and early cigarette smoking and nicotine dependence phenotypes in adolescents. O'Loughlin J; Sylvestre MP; Labbe A; Low NC; Roy-Gagnon MH; Dugas EN; Karp I; Engert JC PLoS One; 2014; 9(12):e115716. PubMed ID: 25545355 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. David SP; Brown RA; Papandonatos GD; Kahler CW; Lloyd-Richardson EE; Munafò MR; Shields PG; Lerman C; Strong D; McCaffery J; Niaura R Nicotine Tob Res; 2007 Aug; 9(8):821-33. PubMed ID: 17654295 [TBL] [Abstract][Full Text] [Related]
5. Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Perkins KA; Lerman C; Grottenthaler A; Ciccocioppo MM; Milanak M; Conklin CA; Bergen AW; Benowitz NL Behav Pharmacol; 2008 Sep; 19(5-6):641-9. PubMed ID: 18690118 [TBL] [Abstract][Full Text] [Related]
6. Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence. Wessel J; McDonald SM; Hinds DA; Stokowski RP; Javitz HS; Kennemer M; Krasnow R; Dirks W; Hardin J; Pitts SJ; Michel M; Jack L; Ballinger DG; McClure JB; Swan GE; Bergen AW Neuropsychopharmacology; 2010 Nov; 35(12):2392-402. PubMed ID: 20736995 [TBL] [Abstract][Full Text] [Related]
8. The association of dopamine pathway gene score, nicotine dependence and smoking cessation in a rural male population of Shandong, China. Li S; Wang Q; Pan L; Li H; Yang X; Jiang F; Zhang N; Han M; Jia C Am J Addict; 2016 Sep; 25(6):493-8. PubMed ID: 27490263 [TBL] [Abstract][Full Text] [Related]
9. Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population. Sieminska A; Buczkowski K; Jassem E; Niedoszytko M; Tkacz E BMC Med Genet; 2009 Sep; 10():92. PubMed ID: 19761593 [TBL] [Abstract][Full Text] [Related]
10. Genetic and Epigenetic Analysis Revealing Variants in the NCAM1-TTC12-ANKK1-DRD2 Cluster Associated Significantly With Nicotine Dependence in Chinese Han Smokers. Liu Q; Xu Y; Mao Y; Ma Y; Wang M; Han H; Cui W; Yuan W; Payne TJ; Xu Y; Li MD; Yang Z Nicotine Tob Res; 2020 Jul; 22(8):1301-1309. PubMed ID: 31867628 [TBL] [Abstract][Full Text] [Related]
11. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Li MD; Beuten J; Ma JZ; Payne TJ; Lou XY; Garcia V; Duenes AS; Crews KM; Elston RC Hum Mol Genet; 2005 May; 14(9):1211-9. PubMed ID: 15790597 [TBL] [Abstract][Full Text] [Related]
12. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. David SP; Strong DR; Leventhal AM; Lancaster MA; McGeary JE; Munafò MR; Bergen AW; Swan GE; Benowitz NL; Tyndale RF; Conti DV; Brown RA; Lerman C; Niaura R Addiction; 2013 Dec; 108(12):2202-11. PubMed ID: 23941313 [TBL] [Abstract][Full Text] [Related]
13. Smoking Genes: A Case-Control Study of Dopamine Transporter Gene ( Ruzilawati AB; Islam MA; Muhamed SKS; Ahmad I Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287325 [TBL] [Abstract][Full Text] [Related]
14. Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependence. Johnson EO; Chen LS; Breslau N; Hatsukami D; Robbins T; Saccone NL; Grucza RA; Bierut LJ Addiction; 2010 Nov; 105(11):2014-22. PubMed ID: 20840187 [TBL] [Abstract][Full Text] [Related]
15. Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence. Ling D; Niu T; Feng Y; Xing H; Xu X J Hum Genet; 2004; 49(1):35-39. PubMed ID: 14685824 [TBL] [Abstract][Full Text] [Related]
16. A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers. Huang W; Payne TJ; Ma JZ; Li MD Am J Med Genet B Neuropsychiatr Genet; 2008 Oct; 147B(7):1109-15. PubMed ID: 18348205 [TBL] [Abstract][Full Text] [Related]
17. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population. Ohmoto M; Takahashi T; Kubota Y; Kobayashi S; Mitsumoto Y BMC Genet; 2014 Dec; 15():151. PubMed ID: 25526961 [TBL] [Abstract][Full Text] [Related]
18. Association of CHRNA4 polymorphisms with smoking behavior in two populations. Han S; Yang BZ; Kranzler HR; Oslin D; Anton R; Gelernter J Am J Med Genet B Neuropsychiatr Genet; 2011 Jun; 156B(4):421-9. PubMed ID: 21445957 [TBL] [Abstract][Full Text] [Related]
19. Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence. Lou XY; Ma JZ; Payne TJ; Beuten J; Crew KM; Li MD Hum Genet; 2006 Oct; 120(3):381-9. PubMed ID: 16874522 [TBL] [Abstract][Full Text] [Related]
20. [Association between nicotine dependence and the -521 promoter polymorfism of the dopamine D4 receptor in patients with major depression]. Kótyuk E; Kovács-Nagy R; Faludi G; Urbán R; Rónai Z; Sasvári-Székely M; Székely A Neuropsychopharmacol Hung; 2009 Jun; 11(2):59-67. PubMed ID: 19827313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]